Conducting Remote Regulatory Assessments Questions and Answers
Conducting Remote Regulatory Assessments Questions and Answers Draft Guidance for Industry
Source: fda.gov
Page 6 - Docket Number News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Docket Number. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Docket Number Today - Breaking & Trending Today
ANDA Submissions – Amendments and Requests for Final Approval to Tenta
ANDA Submissions – Amendments and Requests for Final Approval to Tentatively Approved ANDAs
Source: fda.gov
Revising ANDA Labeling Following Revision of the RLD Labeling Guida
Generics Revision 1
Source: fda.gov
Requests for Reconsideration at the Division Level Under GDUFA
This draft guidance provides recommendations on the procedures for applicants of abbreviated new drug applications (ANDAs) that wish to pursue a request for reconsideration within the review discipline at the division level or original signatory authority.
Source: fda.gov
Q5A(R2) Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin
The guidance is intended to describe risk-based principles and mitigation strategies to assure the viral safety of biotechnology products, including the data necessary to submit in a marketing application.
Source: fda.gov